This Biotech Stock 700%: Top Holding After $9.3M Sale
A biotech stock that surged 700% remains a cornerstone of many portfolios even after a sizable last-quarter sale by a...
Determine which funds deliver the best annual risk-adjusted returns and how they stack up. Compare contenders to pick winners.
28,456 articlesA biotech stock that surged 700% remains a cornerstone of many portfolios even after a sizable last-quarter sale by a...
Netflix stock has slipped from its mid-2025 highs, now flirting with a 52-week low. This article explains what that m...
Geopolitics and energy markets collide when Iran tensions rise. This guide digs into how oil stocks historically resp...
Fluor dropped 26% and headlines lit up. But a solid long-term thesis for this EPC powerhouse requires more than a fla...
Niche energy tech stocks can surge on fresh coverage and bullish notes. This guide explains why the nano nuclear ener...
A coalition of rap legends led by Travis Scott takes a bold legal stand at the Supreme Court. This isn’t just a court...
A dramatic streaming deal sparks a rally in Paramount Skydance and reshapes the media landscape. This guide breaks do...
Vanguard's VOOV ETF provides a low-cost value tilt with broad exposure, trading in a choppy market environment as inv...
Oil prices surged this week as markets faced renewed supply worries. The piece outlines practical ways americans can ...
Speculation swirls about whether will trump seek investment to back a wave of automated, robot-driven factories, sign...
A beloved TV figure's passing reminds us that wealth needs a plan. This article draws finance lessons from a storied ...
The U.S. debt held by the public has eclipsed nominal GDP for the first time since World War II, a milestone that cou...